This effect is mediated by the binding of activated glucocorticoid receptors to two 5' promoter-negative glucocorticoid response elements on the ACTH precursor gene pro-opiomelanocortin.

Researchers examine the mechanisms by which glucocorticoid receptor activity, which varies by time of day, modulates tumor progression and how targeting circadian-driven tumor behaviors could be ...